Pee test could spot TB patients skipping meds
NCT ID NCT06526221
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study in India will test a low-cost urine check (IsoScreen) on 900 adults being treated for tuberculosis. The test detects whether they have taken their medication recently. Researchers want to see if the test can reliably find people who are missing doses, so that doctors can offer extra help. The goal is to reduce deaths, treatment failure, and TB coming back.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- urine isoniazid test (IsoScreen)
- What this could lead to
- If successful, this could give doctors a cheap, quick way to spot when TB patients miss their pills, allowing them to offer extra support and reduce deaths or relapse.
- What could go wrong
- This is an observational study, not a treatment trial. The test may not work well in routine clinic visits, and even if it detects missed doses, it may not improve outcomes on its own.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MEDICATION ADHERENCE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
ICMR-National Institute for Research in Tuberculosis (ICMR-NIRT)
Chennai, Tamil Nadu, India
-
ICMR-National Institute for Research in Tuberculosis (ICMR-NIRT)
Thanjavur, Tamil Nadu, India
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new patient cohort unlock the secrets of TB treatment success?
- Can a smartphone app help people stick to their meds?
- Shorter TB treatment: a 4-Month regimen put to the test
- A new approach to dementia care: families team up on medications
- Lung damage after TB: a new study tests whether rehabilitation can restore breathing and quality of life
- Smartphone messages may boost medication adherence after liver transplant